Ligand Pharmaceuticals (LGND) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn | 21.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.34% |
| Dec 31, 2025 | -21.18% |
| Sep 30, 2025 | 5.39% |
| Jun 30, 2025 | 1.72% |
| Mar 31, 2025 | -4.67% |
| Dec 31, 2024 | -10.25% |
| Sep 30, 2024 | 15.86% |
| Jun 30, 2024 | 2.68% |
| Mar 31, 2024 | -4.44% |
| Dec 31, 2023 | -16.92% |
| Sep 30, 2023 | -3.83% |
| Jun 30, 2023 | -0.69% |
| Mar 31, 2023 | 1.61% |
| Dec 31, 2022 | 66.63% |
| Sep 30, 2022 | 26.00% |
| Jun 30, 2022 | 13.07% |
| Mar 31, 2022 | 19.15% |
| Dec 31, 2021 | 20.09% |
| Sep 30, 2021 | 21.26% |
| Jun 30, 2021 | 28.52% |
| Mar 31, 2021 | 22.65% |
| Dec 31, 2020 | 3.50% |
| Sep 30, 2020 | 13.83% |
| Jun 30, 2020 | 16.75% |
| Mar 31, 2020 | -2.21% |
| Dec 31, 2019 | 6.58% |
| Sep 30, 2019 | 8.54% |
| Jun 30, 2019 | 12.23% |
| Mar 31, 2019 | 9.10% |
| Dec 31, 2018 | 26.81% |
| Sep 30, 2018 | 24.48% |
| Jun 30, 2018 | 8.56% |
| Mar 31, 2018 | 16.06% |
| Dec 31, 2017 | 53.76% |
| Sep 30, 2017 | 12.34% |
| Jun 30, 2017 | 15.18% |
| Mar 31, 2017 | 43.01% |
| Dec 31, 2016 | 50.81% |
| Sep 30, 2016 | 47.55% |
| Jun 30, 2016 | 46.05% |
| Mar 31, 2016 | 54.16% |
| Dec 31, 2015 | 45.79% |
| Sep 30, 2015 | 40.94% |
| Jun 30, 2015 | 39.21% |
| Mar 31, 2015 | 60.18% |
| Dec 31, 2014 | 51.98% |
| Sep 30, 2014 | 57.36% |
| Jun 30, 2014 | 35.33% |
| Mar 31, 2014 | 65.98% |
| Dec 31, 2013 | 69.59% |
| Sep 30, 2013 | 40.14% |